- Tags: MIGS
Products
Sight Sciences debuts OMNI Edge Surgical System
Launching during ASCRS, this new hand-held and single-use MIGS device features the company’s patented, higher-capacity viscoelastic delivery TruSync technology.
Events
Registration is now open for Eyes On Glaucoma 2025
Largest virtual glaucoma-focused event of the year highlights the latest advancements in disease care and offers up to 4.5 hours of COPE-accredited CE.
Research
Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma
New study details favorable safety profile of the CycloPen System as a bio-interventional platform for OAG patients undergoing combined cataract surgery.
Products
Haag-Streit launches METIS 900 surgical control center
Newest ophthalmic microscope system features coaxial red reflex, LED illumination, ergonomically-friendly controls, and a compact design.
Business
Iantrek names former Trukera Medical leader as new CEO
Adam Szaronos joins the biotechnology company as it plans a full commercial launch of two surgical glaucoma devices later this year.
Research
High-risk POAG patients less likely to undergo MIGS
Study finds Black patients in the U.S. undergo MIGS at a lower rate than their White counterparts.
Research
Real-world data confirms long-term efficacy of OMNI Surgical System for POAG
Sight Sciences announces 36-month findings demonstrating continued effectiveness of standalone OMNI surgery with either IOP or medication reductions over time.
Business
Bausch + Lomb purchases Elios Vision
Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Research
MIGS' rising popularity is shifting glaucoma candidate demographics
New analysis finds baseline features of glaucoma patients are trending younger over the last 10 years.
Products
FDA clears Oertli's Faros anterior cataract surgery system
Latest surgical system features a compact design and offers rapid operational readiness in under 1 minute.
Business
Alcon officially acquires BELKIN Vision
Purchase involves the Israeli company’s FDA-cleared direct selective laser trabeculoplasty technology.Business
Alcon is buying Belkin Vision and its contact-less SLT glaucoma device
Acquisition is estimated to be worth up to $335 million and will close in Q3 2024.
Legal
Alcon faces penalty over Sight Sciences patent infringement
Jury trial rules that Alcon willfully infringed on three Sight Sciences patents, compelling them to pay $34 million in monetary damages.
Research
Sight Sciences reports real-world data on leading MIGS devices, including OMNI Surgical System
Large-scale, comparative study also evaluated the Hydrus Microstent and iStent inject for lowering IOP in 100,000+ glaucoma patients’ eyes.
Research
AAO panel finds potential IOP benefits to MIGS-cataract combined surgical approach
Literature search report examines RCTs involving patients with mild-to-moderate open-angle glaucoma.
Research
New 2-year MIGS data supports TCOR using the OMNI Surgical System
Real-world study examined the use of three different MIGS devices against cataract surgery alone for treating IOP.
Research